A Unitary Mechanism of Calcium Antagonist Drug Action

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1983 Feb 1

PMID 6572372

Citations 34

Authors

K M Murphy

R J Gould

B L Largent

S H Snyder

Affiliations

Soon will be listed here.

Abstract

[3H]Nitrendipine binding to drug receptor sites associated with calcium channels is allosterically regulated by a diverse group of calcium channel antagonists. Verapamil, D-600 (methoxyverapamil), tiapamil, lidoflazine, flunarizine, cinnarizine, and prenylamine all reduce [3H]nitrendipine binding affinity. By contrast, diltiazem, a benzothiazepine calcium channel antagonist, enhances [3H]nitrendipine binding. All these drug effects involve a single site allosterically linked to the [3H]nitrendipine binding site. Inhibition of [3H]nitrendipine binding by prenylamine, lidoflazine, or tiapamil is reversed by D-600 and diltiazem, which alone respectively slightly reduce or enhance [3H]nitrendipine binding. Diltiazem reverses the inhibition of [3H]nitrendipine binding by D-600. Our prediction that drugs allosterically regulating [3H]nitrendipine binding should be calcium antagonists is confirmed by calcium antagonism in guinea pig ileum observed with the antihistamine dimethindene, the neuroleptics thioridazine and mesoridazine, and the anticholinergic biperiden.

Citing Articles

Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology.

Catterall W Channels (Austin). 2023; 17(1):2281714.

PMID: 37983307 PMC: 10761118. DOI: 10.1080/19336950.2023.2281714.

Structural Basis for Diltiazem Block of a Voltage-Gated Ca Channel.

Tang L, Gamal El-Din T, Lenaeus M, Zheng N, Catterall W Mol Pharmacol. 2019; 96(4):485-492.

PMID: 31391290 PMC: 6738535. DOI: 10.1124/mol.119.117531.

High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?.

Alexandre J, Humbert X, Sassier M, Milliez P, Coquerel A, Fedrizzi S Drug Saf Case Rep. 2016; 2(1):13.

PMID: 27747725 PMC: 5005783. DOI: 10.1007/s40800-015-0015-3.

Structural basis for inhibition of a voltage-gated Ca channel by Ca antagonist drugs.

Tang L, Gamal El-Din T, Swanson T, Pryde D, Scheuer T, Zheng N Nature. 2016; 537(7618):117-121.

PMID: 27556947 PMC: 5161592. DOI: 10.1038/nature19102.

Identification of a novel calcium antagonist binding site in rat brain by SR 33557.

Kenny B, Fraser S, Spedding M Br J Pharmacol. 1993; 108(1):93-9.

PMID: 7679034 PMC: 1907724. DOI: 10.1111/j.1476-5381.1993.tb13445.x.

References

Nagao T, Sato M, Nakajima H, KIYOMOTO A . Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship. Chem Pharm Bull (Tokyo). 1973; 21(1):92-7. DOI: 10.1248/cpb.21.92. View

FLECKENSTEIN A . Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977; 17:149-66. DOI: 10.1146/annurev.pa.17.040177.001053. View

Nyberg G, Axelsson R, MARTENSSON E . Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur J Clin Pharmacol. 1978; 14(5):341-50. DOI: 10.1007/BF00611904. View

Rosenberger L, Ticku M, Triggle D . The effect of Ca2+ antagonists on mechanical responses and Ca2+ movements in guinea pig ileal longitudinal smooth muscle. Can J Physiol Pharmacol. 1979; 57(4):333-47. DOI: 10.1139/y79-052. View

Vogel S, Crampton R, Sperelakis N . Blockade of myocardial slow channels by bepridil (CERM-1978). J Pharmacol Exp Ther. 1979; 210(3):378-85. View

Triggle C, Swamy V, Triggle D . Calcium antagonists and contractile responses in rat vas deferens and guinea pig ileal smooth muscle. Can J Physiol Pharmacol. 1979; 57(8):804-18. DOI: 10.1139/y79-124. View

Calil H, Avery D, Hollister L, Creese I, Snyder S . Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations. Psychiatry Res. 1979; 1(1):39-44. DOI: 10.1016/0165-1781(79)90026-x. View

Henry P . Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980; 46(6):1047-58. DOI: 10.1016/0002-9149(80)90366-5. View

Eigenmann R, Blaber L, Nakamura K, Thorens S, Haeusler G . Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies. Arzneimittelforschung. 1981; 31(9):1393-401. View

10.

Jim K, Harris A, Rosenberger L, Triggle D . Stereoselective and non-stereoselective effects of D 600 (methoxyverapamil) in smooth muscle preparations. Eur J Pharmacol. 1981; 76(1):67-72. DOI: 10.1016/0014-2999(81)90010-8. View

11.

APPLETON W . Fourth psychoactive drug usage guide. J Clin Psychiatry. 1982; 43(1):12-27. View

12.

Gould R, Murphy K, Snyder S . [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists. Proc Natl Acad Sci U S A. 1982; 79(11):3656-60. PMC: 346482. DOI: 10.1073/pnas.79.11.3656. View

13.

Bellemann P, Ferry D, Lubbecke F, Glossmann H . [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Arzneimittelforschung. 1982; 32(4):361-3. View

14.

Ehlert F, Roeske W, Itoga E, Yamamura H . The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci. 1982; 30(25):2191-202. DOI: 10.1016/0024-3205(82)90293-4. View

15.

Ferry D, Glossmann H . Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol. 1982; 321(1):80-3. DOI: 10.1007/BF00586355. View

16.

Depover A, Matlib M, Lee S, Dube G, GRUPP I, GRUPP G . Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun. 1982; 108(1):110-7. DOI: 10.1016/0006-291x(82)91838-1. View

17.

Yamamura H, Schoemaker H, Boles R, Roeske W . Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Commun. 1982; 108(2):640-6. DOI: 10.1016/0006-291x(82)90877-4. View

18.

Murphy K, Snyder S . Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. Eur J Pharmacol. 1982; 77(2-3):201-2. DOI: 10.1016/0014-2999(82)90021-8. View

19.

Bolger G, Gengo P, Luchowski E, Siegel H, Triggle D, Janis R . High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem Biophys Res Commun. 1982; 104(4):1604-9. DOI: 10.1016/0006-291x(82)91436-x. View

20.

Soffer J, DREIFUS L, Michelson E . Polymorphous ventricular tachycardia associated with normal and long Q-T intervals. Am J Cardiol. 1982; 49(8):2021-9. DOI: 10.1016/0002-9149(82)90224-7. View